Tag Archives: Dow

Keeping Up To Date On CRISPR – July 2016

CRISPR is a gene editing technique that promises to revolutionize genetic engineering, but already is raising ethical, business, and legal issues. This article provides a snapshot of CRISPR technology and patent application filings. If you are interested in more information, please download a digital copy of our web conference on “Navigating the CRISPR Patent Landscape and Business … Continue reading this entry

Court Finds Dow Claims Clearly Indefinite

In Dow Chemical Co. v. Nova Chemicals Corp., the Federal Circuit held claims reciting a limitation that could be calculated in several ways indefinite where the patent claims, specification, and prosecution history failed to indicate which method should be used. For those wondering whether the “reasonable certainty” standard set forth in the Supreme Court’s Nautilus decision will … Continue reading this entry